Synonn Lifesciences Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 2008.
2008 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Synonn Lifesciences Limited

Synonn Lifesciences Limited, a struck off public limited company, was established on 12 December 2008 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51397DL2008PLC185780. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.77 M and a paid-up capital of ₹2.77 M.

It upholds a compliant status. Employing 10 professional, Its leadership includes Krishnendu Kumar Dey (Director), Rahul Rangrao Patil (Director), Rajendra Kishorilal Goyal (Director). Past directors included Sanjay Kumar Chawala, Dinesh Kumar Talwar, Rajendra Kishorilal Goyal. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 305, Jaina Tower Ii District Centre, Janakpuri, New Delhi, Delhi, 110058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397DL2008PLC185780

  • Registration Number

    185780

  • Incorporation Date

    12 December 2008

  • Authorized Capital

    ₹2.77 M

  • Paid-Up Capital

    ₹2.77 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 2.77 M
  • Paid Up Capital ₹ 2.77 M
  • Company Age 17 Year, 2 Months
  • Last Filing with ROC 31 Mar 2019
  • Revenue Growth **** 3.61%
  • Profit Growth **** -54.74%
  • Ebitda **** -80.12%
  • Net Worth 0.61%
  • Total Assets -5.57%
Company report

Synonn Lifesciences Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Synonn Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synonn Lifesciences Limited?
Current Directors
Name Designation Appointment Date Status
Krishnendu Kumar Dey Director 12 Dec 2008 Current
Rahul Rangrao Patil Director 12 Dec 2008 Current
Rajendra Kishorilal Goyal Director 02 Sep 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2009 Past
Pramod Abcsdd Director 02 Sep 2013 Past
Pramod Abcsdd Additional Director 30 Sep 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synonn Lifesciences.

Synonn Lifesciences Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 3.61% increase. The company also saw a substantial fall in profitability, with a 54.74% decrease in profit. The company's net worth moved up by a moderate rise of 0.61%.

Synonn Lifesciences revenue growth over time
Synonn Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.61%
*******
*******
*******
*******
Revenue from Operations
*******
 3.39%
*******
*******
*******
*******
Total Assets
*******
 -5.57%
*******
*******
*******
*******
Profit or Loss
*******
 -54.74%
*******
*******
*******
*******
Net Worth
*******
 0.61%
*******
*******
*******
*******
EBITDA
*******
 -80.12%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synonn Lifesciences?

In 2017, Synonn Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Synonn Lifesciences?

Synonn Lifesciences has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synonn Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synonn Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synonn Lifesciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Synonn Lifesciences Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Synonn Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi. was completed.

  • Director Appointment

    Rajendra Kishorilal Goyal was appointed as a Director was appointed as a Director on 02 Sep 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Krishnendu Kumar Dey was appointed as a Director was appointed as a Director on 12 Dec 2008 & has been associated with this company since 17 years 2 months . was completed.

  • Director Appointment

    The activity Rahul Rangrao Patil was appointed as a Director was appointed as a Director on 12 Dec 2008 & has been associated with this company since 17 years 2 months . was completed.

  • Company Incorporation

    Progress on Synonn Lifesciences Limited was registered on 12 Dec 2008 with Roc Delhi & aged 17 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synonn Lifesciences Limited?

The CIN of Synonn Lifesciences Limited is U51397DL2008PLC185780.

Where is Synonn Lifesciences Limited headquartered?

Synonn Lifesciences Limited is headquartered at 305, Jaina Tower Ii District Centre, Janakpuri, New Delhi, Delhi, 110058.

When was Synonn Lifesciences Limited incorporated?

Synonn Lifesciences Limited was incorporated on 12 December 2008.

Who are the current directors of Synonn Lifesciences Limited?

The current directors of Synonn Lifesciences Limited are

What is the primary industry of Synonn Lifesciences Limited?

The primary industry of Synonn Lifesciences Limited is Manufacturing.

Is Synonn Lifesciences Limited a listed company?

Synonn Lifesciences Limited is unlisted.

What is the capital structure of Synonn Lifesciences Limited?

The authorized capital of Synonn Lifesciences Limited is ₹2.77 M, and the paid-up capital is ₹2.77 M.

What is the compliance status of Synonn Lifesciences Limited?

The compliance status of Synonn Lifesciences Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available